| PERIOD ENDING | 28-Feb-09 | 29-Feb-08 | 28-Feb-07 | | Total Revenue | 584,029 | 610,610 | 584,713 | | Cost of Revenue | 440,553 | 457,963 | 438,776 | | | Gross Profit | 143,476 | 152,647 | 145,937 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 86,217 | 77,624 | 72,579 | | Non Recurring | 67,337 | (757) |
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (10,078) | 75,780 | 73,358 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 382 | (317) | (57) | | Earnings Before Interest And Taxes | (9,696) | 75,463 | 73,301 | | Interest Expense | 3,363 | 5,678 | 6,936 | | Income Before Tax | (13,059) | 69,785 | 66,365 | | Income Tax Expense | 19,709 | 25,195 | 24,764 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (32,768) | 44,590 | 41,601 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (32,768) | 44,590 | 41,601 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($32,768) | $44,590 | $41,601 |
|
0.22% Nasdaq 0.00%
Income Statement
